A. A. Latypov

Multicenter retrospective cohort study of patients with locally advanced gastric and esophagogastric junction cancer, who achieved pathological complete response: incidence, patterns and predictors of disease progression (report 3)

Background. Pathological complete response (pCR, ypT0N0) after neoadjuvant therapy is regarded as an exceptionally favorable prognostic factor in locally advanced gastric and esophagogastric junction cancer. The incidence of disease progression in this subgroup and the factors that might predict it remain insufficie...